Association of a probiotic to a Helicobacter pylorieradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study

Table 4 Incidence of adverse effects in groups of active and placebo probiotic at 7 and 30-day visits

Visit	Active probiotic	Placebo probiotic	p
7 day	32/54 (59.3%)	37/52 (71.2%)	0.20
30 day	21/49 (44.9%)	29/48 (60.4%)	0.08

ISSN: 1471-230X